Trials / Completed
CompletedNCT01941589
Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis
Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The role of steroids in the treatment of ulcerative Colitis (UC) is well established, and recommended by professional societies. However, there are no data investigating whether the addition and/or continuation of 5-aminosalicylic agents as combination therapy with systemic corticosteroids is superior to corticosteroids alone in patients with moderate-severe active UC. Thus, in practical terms, the decision regarding 5-aminosalicylic (to add or continue), on top of steroids treatment, is taken on an arbitrary basis. The aim of this study is to compare the efficacy of steroids alone Vs combination of steroids + 5-aminosalicylic in the treatment of moderate-severe UC exacerbation.
Detailed description
he role of steroids in the treatment of ulcerative Colitis (UC) is well established, and recommended by professional societies. However, there are no data investigating whether the addition and/or continuation of 5-aminosalicylic agents as combination therapy with systemic corticosteroids is superior to corticosteroids alone in patients with moderate-severe active UC. Thus, in practical terms, the decision regarding 5-aminosalicylic (to add or continue), on top of steroids treatment, is taken on an arbitrary basis. The aim of this study is to compare the efficacy of steroids alone Vs combination of steroids + 5-aminosalicylic in the treatment of moderate-severe UC exacerbation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | maximal oral 5-ASA+/-topical 5-ASA+IV corticosteroids |
| DRUG | corticosteroids only | IV corticosteroids only |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2013-09-13
- Last updated
- 2022-05-09
Locations
10 sites across 7 countries: China, France, Greece, Israel, Italy, Serbia, South Korea
Source: ClinicalTrials.gov record NCT01941589. Inclusion in this directory is not an endorsement.